For research use only
| Cat No. | ABC-X0126C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Host Cell | CHOK1 |
| Source Organ | Ovary |
| Disease | Normal |
| Storage | Liquid Nitrogen |
FCGR2A (R167) CHOK1 Cell Line facilitates the analysis of Fc receptor signaling and aids therapeutic antibody development for immune diseases.
Human FCGR2A_R167 CHOK1 Cell Line is a stable CHOK1-derived model engineered to express the low-affinity Fc gamma receptor IIA (CD32A) with the R167 variant. Transduction is performed using lentiviral vectors, with transgene expression confirmed via qRT-PCR and passages kept below 20.
Target
FCGR2A (CD32A) mediates IgG immune complex recognition, phagocytosis, and cytokine release. The R167 variant influences receptor affinity and downstream immune activation, with implications in autoimmunity and immunotherapy efficacy. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0126C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Ovary |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | CHOK1 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model is ideal for investigating Fc receptor biology, antibody effector function, and the development of Fc-engineered therapeutic antibodies. It enables high-throughput assessment of IgG subclass interactions and immune modulation.